Alnylam Pharmaceuticals (ALNY) ROA US GAAP (year values) |
||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | |||
| ROA, % | ? | -23.4% | -31.9% | -11.5% | -6.56% | 6.32% | 11.3% | |
| Changes by years, y/y, % | +2pp | -8pp | +20pp | +5pp | +13pp | |||
Alnylam Pharmaceuticals. ROA, %
Alnylam Pharmaceuticals. ROA, changes, pp
Alnylam Pharmaceuticals (ALNY) ROA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| ROA, % | ? | -6.40% | -6.99% | 0.90% | 6.32% | 11.3% | 11.3% | |
| Changes by years, y/y, % | +2pp | -5pp | +9pp | +13pp | +18pp | |||
| Changes by quarters, q/q, % | +0pp | -1pp | +8pp | +5pp | +5pp | |||